Picture of Ascelia Pharma AB logo

ACE Ascelia Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Ascelia Pharma: First Commercial Scale Manufacturing Of Mangoral

Sept 18 (Reuters) - Ascelia Pharma AB  ACELP.ST :
    * FIRST COMMERCIAL SCALE MANUFACTURING OF MANGORAL
    * REACHED A KEY ACHIEVEMENT WITH FIRST COMMERCIAL SCALE
MANUFACTURING OF ITS LEAD COMPOUND MANGORAL, CURRENTLY IN
PIVOTAL PHASE 3 DEVELOPMENT
    * FIRST AND REPRODUCEABLE COMMERCIAL SCALE MANUFACTURING IS
AN
IMPORTANT STEP TOWARDS A PRODUCT APPROVAL AND LAUNCH, WHICH WE
EXPECT IN LATE 2022 OR BEGINNING OF 2023

Source text for Eikon:  ID:nWkr7SZQnd 
Further company coverage:  ACELP.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Ascelia Pharma AB

See all news